GBT is now part of Pfizer! Click here for more information.


GBT is determined to be a catalyst for change and committed to improving the care of people living with sickle cell disease

Our work goes beyond discovering and developing novel therapeutics

We’re also dedicated advocates for the patients who need them

Learn more